In this article, the author discusses oral anticoagulants and all the current information on these drugs. A home anticoagulation monitoring program is presented that may be used as a model for any agency. A nursing care plan is also included.
Get full access to this article
View all access options for this article.
References
1.
Wessler S., Gitel S.Warfarin: From bedside to bench. N Engl J Med.1984;311:645-652.
2.
Sawyer W.Management of thromboembolic disease. US Pharmacist . 1989;14(12):H1-H30.
Shetty H., Fennerty A., Routledge P.Clinical pharmacokinetic considerations in the control of oral anticoagulant therapy. Clin Pharmacokinet.1989;16:238-253.
5.
McEvoy G, ed. AHFS Drug Information. Bethesda, Md: American Society of Hospital Pharmacists , 1991.
6.
Briggs G, Freeman R, Yaffe S, eds. Drugs in Pregnancy and Lactation. Baltimore, Md: Williams & Wilkins; 1988.
7.
Jaffin B., Bliss C., Lamont J.Significance of occult gastrointestinal bleeding during anticoagulation therapy . Am J Med.1987;83:269-272.
8.
Serlin J., Breckenridge A. Drug interactions with warfarin. Drugs. 1983;25:610-620.
